{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:01:34Z","timestamp":1784851294751,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["T11-705\/21-N"],"award-info":[{"award-number":["T11-705\/21-N"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Omicron SARS-CoV-2 has diversified into multiple sub-lineages, complicating assessment of their intrinsic phenotypes due to background population immunity. We compare replication and biological characteristics of variants from BA.1 to JN.1 using human bronchial and lung explants, airway organoids, colon cells, and proximal intestinal enteroids. XBB.1.5 and EG.5.1 achieve higher replication titres in respiratory tissues than BA.2.86 and JN.1, indicating enhanced respiratory fitness. EG.5.1 displays dual cell-entry pathways and greater replication in alveolar epithelial cells, supporting increased lung tropism and pathogenicity. In contrast, BA.2.86 and JN.1 rely on TMPRSS2-mediated entry in airways. Notably, BA.2.86 and JN.1 replicate more efficiently than EG.5.1 in proximal intestinal enteroids in an ACE2- and TMPRSS2-dependent manner, but not in colon cells. JN.1 exhibits elevated intestinal tropism with limited proinflammatory cytokine induction, suggesting potential for faecal transmission. Here we show XBB.1.5 and EG.5.1 greater transmissibility and severity potential whereas BA.2.86 and JN.1 exhibit enhanced intestinal adaptation.<\/jats:p>","DOI":"10.1038\/s41467-026-74111-y","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:03:41Z","timestamp":1780628621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 Omicron BA.2.86 and JN.1 expand tropism in human proximal intestinal epithelium"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-0535","authenticated-orcid":false,"given":"Kenrie PY","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John CW","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Chun","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny CM","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor WC","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel HH","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-7953","authenticated-orcid":false,"given":"Leo LM","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8217-5995","authenticated-orcid":false,"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7217-7444","authenticated-orcid":false,"given":"John M","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-8405","authenticated-orcid":false,"given":"Michael CW","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"74111_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46490-7","volume":"15","author":"D Planas","year":"2024","unstructured":"Planas, D. et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat. Commun. 15, 2254 (2024).","journal-title":"Nat. Commun."},{"key":"74111_CR2","first-page":"1900","volume":"382","author":"O Dyer","year":"2023","unstructured":"Dyer, O. Covid-19: Infections climb globally as EG.5 variant gains ground. BMJ (Clin. Res. ed.) 382, 1900 (2023).","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"74111_CR3","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1016\/S1473-3099(23)00555-8","volume":"23","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6.  Lancet Infect. Dis. 23, e397\u2013e398 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46025-y","volume":"13","author":"N Patel","year":"2023","unstructured":"Patel, N. et al. XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants. Sci. Rep. 13, 19176 (2023).","journal-title":"Sci. Rep."},{"key":"74111_CR5","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1016\/S1473-3099(23)00547-9","volume":"23","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3.  Lancet Infect. Dis. 23, e391\u2013e392 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5582\/ddt.2024.01008","volume":"18","author":"G Ou","year":"2024","unstructured":"Ou, G. et al. Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact. Drug Discov. Ther. 18, 67\u201370 (2024).","journal-title":"Drug Discov. Ther."},{"key":"74111_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","volume":"187","author":"P Qu","year":"2024","unstructured":"Qu, P. et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell 187, 585\u2013595 e586 (2024).","journal-title":"Cell"},{"key":"74111_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s15010-023-02146-0","volume":"52","author":"A Esmaeilzadeh","year":"2024","unstructured":"Esmaeilzadeh, A., Ebrahimi, F., Jahani Maleki, A. & Siahmansouri, A. EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19. Infection 52, 337\u2013343 (2024).","journal-title":"Infection"},{"key":"74111_CR9","doi-asserted-by":"publisher","unstructured":"Jeworowski, L.M. et al. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 29 https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.2.2300740 (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300740"},{"key":"74111_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107028","volume":"143","author":"J Favresse","year":"2024","unstructured":"Favresse, J. et al. Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1, and JN.1 six months after the BNT162b2 bivalent booster. Int J. Infect. Dis. 143, 107028 (2024).","journal-title":"Int J. Infect. Dis."},{"key":"74111_CR11","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1016\/S1473-3099(23)00575-3","volume":"23","author":"K Uriu","year":"2023","unstructured":"Uriu, K. et al. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant.  Lancet Infect. Dis. 23, e460\u2013e461 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.chom.2024.01.001","volume":"32","author":"T Tamura","year":"2024","unstructured":"Tamura, T. et al. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell host microbe 32, 170\u2013180 e112 (2024).","journal-title":"Cell host microbe"},{"key":"74111_CR13","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku, Y. et al. Virological characteristics of the SARS-CoV-2 JN.1 variant.  Lancet Infect. Dis. 24, e82 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","volume":"187","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell 187, 596\u2013608.e517 (2024).","journal-title":"Cell"},{"key":"74111_CR15","doi-asserted-by":"publisher","unstructured":"Antia, A. et al. SARS-CoV-2 omicron BA.1 variant infection of human colon epithelial cells. Viruses 16 https:\/\/doi.org\/10.3390\/v16040634 (2024).","DOI":"10.3390\/v16040634"},{"key":"74111_CR16","doi-asserted-by":"publisher","first-page":"e3001592","DOI":"10.1371\/journal.pbio.3001592","volume":"20","author":"KK Jang","year":"2022","unstructured":"Jang, K. K. et al. Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection. PLoS Biol. 20, e3001592 (2022).","journal-title":"PLoS Biol."},{"key":"74111_CR17","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","volume":"136","author":"HB Greenberg","year":"2009","unstructured":"Greenberg, H. B. & Estes, M. K. Rotaviruses: from pathogenesis to vaccination. Gastroenterology 136, 1939\u20131951 (2009).","journal-title":"Gastroenterology"},{"key":"74111_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15999-y","volume":"11","author":"V Cortez","year":"2020","unstructured":"Cortez, V. et al. Astrovirus infects actively secreting goblet cells and alters the gut mucus barrier. Nat. Commun. 11, 2097 (2020).","journal-title":"Nat. Commun."},{"key":"74111_CR19","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1016\/S1473-3099(24)00155-5","volume":"24","author":"DL Wannigama","year":"2024","unstructured":"Wannigama, D. L. et al. Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1.  Lancet Infect. Dis. 24, e348\u2013e350 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR20","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure.  Lancet Infect. Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"74111_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","volume":"607","author":"R Uraki","year":"2022","unstructured":"Uraki, R. et al. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2. Nature 607, 119\u2013127 (2022).","journal-title":"Nature"},{"key":"74111_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113580","volume":"42","author":"R Uraki","year":"2023","unstructured":"Uraki, R. et al. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell Rep. 42, 113580 (2023).","journal-title":"Cell Rep."},{"key":"74111_CR23","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1016\/j.cell.2022.09.018","volume":"185","author":"I Kimura","year":"2022","unstructured":"Kimura, I. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell 185, 3992\u20134007.e3916 (2022).","journal-title":"Cell"},{"key":"74111_CR24","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381 (2022).","journal-title":"Rev. Med. Virol."},{"key":"74111_CR25","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s42003-023-05081-w","volume":"6","author":"T Tamura","year":"2023","unstructured":"Tamura, T. et al. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Commun. Biol. 6, 772 (2023).","journal-title":"Commun. Biol."},{"key":"74111_CR26","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1073\/pnas.2002589117","volume":"117","author":"S Matsuyama","year":"2020","unstructured":"Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. USA. 117, 7001\u20137003 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74111_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"74111_CR28","doi-asserted-by":"publisher","unstructured":"Hui, K. P. et al. Tropism and innate host responses of influenza A\/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract. Eur. Respir. J. 49 https:\/\/doi.org\/10.1183\/13993003.01710-2016 (2017).","DOI":"10.1183\/13993003.01710-2016"},{"key":"74111_CR29","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S2213-2600(18)30236-4","volume":"6","author":"KPY Hui","year":"2018","unstructured":"Hui, K. P. Y. et al. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures.  Lancet Respiratory Med. 6, 846\u2013854 (2018).","journal-title":"Lancet Respiratory Med."},{"key":"74111_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers, M. M. et al. SARS-CoV-2 productively infects human gut enterocytes. Sci. (N.Y., N.Y.) 369, 50\u201354 (2020).","journal-title":"Sci. (N.Y., N.Y.)"},{"key":"74111_CR31","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aaf5211","volume":"353","author":"K Ettayebi","year":"2016","unstructured":"Ettayebi, K. et al. Replication of human noroviruses in stem cell-derived human enteroids. Sci. (N.Y., N.Y.) 353, 1387\u20131393 (2016).","journal-title":"Sci. (N.Y., N.Y.)"},{"key":"74111_CR32","doi-asserted-by":"publisher","unstructured":"Mahe, M. M., Sundaram, N., Watson, C. L., Shroyer, N. F. & Helmrath, M. A. Establishment of human epithelial enteroids and colonoids from whole tissue and biopsy. J. Vis. Exp. https:\/\/doi.org\/10.3791\/52483 (2015).","DOI":"10.3791\/52483"},{"key":"74111_CR33","doi-asserted-by":"publisher","unstructured":"Chan, J. C. M., Mohammad, K. N., Zhang, L. Y., Wong, S. H. & Chan, M. C. Targeted Profiling of Immunological Genes during Norovirus Replication in Human Intestinal Enteroids. Viruses 13 https:\/\/doi.org\/10.3390\/v13020155 (2021).","DOI":"10.3390\/v13020155"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74111-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:27:10Z","timestamp":1784849230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74111"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74111-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7187"}}